Industry Metrics for CDISC Controlled Terminology
Sergiy Sirichenko summarizes industry metrics across many studies and sponsors to produce an overall picture…
Certara2021 年 11 月 17 日
Overcome Research Hurdles: Expert Guidance for Complex Generic Drug Development
Do expensive bioequivalence studies stall your generic drug approval? Learn how you can streamline complex…
Certara2021 年 4 月 15 日
Strategic Evidence & Value Communication Symposium
Join us on 2021 年 4 月 21 日, 星期三, from12:00 PM – 2:00 PM EDT for Certara’s…
Certara2021 年 3 月 26 日
Purity is a Virtue: A Practical Guide to the Reporting of Impurities
Many pharmaceutical companies struggle with characterizing drug substance (DS) and drug product (DP) impurities and…
Certara2021 年 3 月 23 日
R Speaks NLME (RsNLME)
Download the brochure to learn more about RsNLME’s features and benefits.
Certara2021 年 3 月 9 日
Scientific Computing World: Connecting Science
Interconnection is an imperative for the modern laboratory, and seamless integration is mandatory from the…
Certara2021 年 3 月 4 日
Prelude Therapeutics reduces their quality control (QC) process for regulatory submissions from hours to minutes with Certara’s GlobalSubmit eCTD Software
In 2019, Prelude Therapeutics, a small cancer drug discovery company, implemented Certara’s GlobalSubmit submissions management…
Certara2021 年 3 月 2 日
Certara Acquires AUTHOR!, a Regulatory and Biostatistics Services Firm in Europe
Broadens European footprint with integrated regulatory services and statistical analysis PRINCETON, NJ.— 2021 年 3 月 2 日–…
Certara2021 年 3 月 2 日
BPS Article: Model‐Informed Drug Repurposing: a Pharmacometric Approach to Novel Pathogen Preparedness, Response and Retrospection
Abstract During a pandemic caused by a novel pathogen (NP), drug repurposing offers the potential…
Certara2021 年 2 月 9 日
